Jalon Therapeutics

Paris, France

Jalon Therapeutics' goal is to create novel therapies that inhibit vital tumour signalling pathways that are currently untargeted.

$465K raised

Nov 2022

Debt Financing

Biopharma Biotechnology

Top Investors

Bpifrance

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Jalon Therapeutics

How much funding has Jalon Therapeutics raised?

Jalon Therapeutics has raised $465K in total funding. The most recent round was Debt Financing. The last funding was announced in November 2022.

Who are Jalon Therapeutics's investors?

Jalon Therapeutics's investors include Bpifrance.

Where is Jalon Therapeutics headquartered?

Jalon Therapeutics is headquartered in Paris, France.

What does Jalon Therapeutics do?

Jalon Therapeutics' goal is to create novel therapies that inhibit vital tumour signalling pathways that are currently untargeted.

What stage is Jalon Therapeutics at?

Jalon Therapeutics is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 29, 2022.

MLA

"Jalon Therapeutics — Funding & Investors." VCBacked, November 29, 2022, https://www.vcbacked.co/company/jalon-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2022). Jalon Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/jalon-therapeutics

Wikipedia (cite web)

{{cite web |title=Jalon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/jalon-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 29, 2022.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.